Vivakor, Inc. (VIVK) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Vivakor, Inc. on February 4, 2026, reporting events occurring on January 30, 2026. The Company, an emerging growth company incorporated in Nevada, is listed on the Nasdaq Capital Market. The filing addresses a material definitive agreement regarding outstanding debt and unregistered equity sales.
Key Financial Metrics and Debt Obligations
The filing details the status of convertible promissory notes ("Lender Notes") issued between June 6, 2025, and June 9, 2025, to seven accredited investors.
- Original Principal Amount: $5,117,647.06
- Net Proceeds Received: $4,350,000 (prior to customary fees)
- Principal Repaid to Date: Approximately $2,874,854
- Outstanding Principal Balance (as of Jan 30, 2026): Approximately $2,242,793
- Equity Issuance: 56,167,665 shares of restricted common stock to be issued to lenders.
Material Changes and Agreement Terms
On January 30, 2026, the Company entered into Forbearance and Note Amendment Agreements with the seven lenders. Key terms include:
- Maturity Extension: The maturity date of the Lender Notes has been extended to January 31, 2027.
- Repayment Schedule: The Company agreed to a specific installment plan to pay off the remaining balance:
- $378,433.25 by March 1, 2026
- $396,414.53 by April 30, 2026
- $258,903.84 by June 30, 2026
- $454,796.89 by July 31, 2026
- $17,433.25 by September 30, 2026
- $356,193.98 by October 31, 2026
- $372,627.23 by January 31, 2027
- Conversion Restrictions: Conversions of notes to equity are prohibited unless the Company defaults on the payment terms or fails to regain Nasdaq listing status by February 28, 2026. This deadline may be extended if the only remaining requirement for relisting is the completion of a reverse stock split.
Outlook, Risks, and Contingencies
The filing highlights significant liquidity and regulatory risks:
- Nasdaq Relisting Risk: The Company faces a critical deadline of February 28, 2026, to be re-listed on Nasdaq. Failure to do so (absent a pending reverse stock split) triggers the right for lenders to convert notes to equity.
- Liquidity Pressure: The Company must generate or secure approximately $774,847.78 in cash within the first two months of the repayment schedule (March and April 2026).
- Dilution: The issuance of 56,167,665 shares represents a material increase in the share count, subject to Rule 144 restrictions.
The filing text does not provide specific revenue, profit, or cash flow figures for the reporting period, nor does it include forward-looking financial guidance beyond the debt repayment schedule.
Investor Verification Checklist
- Verify the Company's current Nasdaq compliance status and the timeline for any pending reverse stock split.
- Confirm the Company's available cash reserves to meet the $378,433.25 payment due March 1, 2026.
- Review the full text of the Forbearance and Note Amendment Agreement (Exhibit 10.1) for default clauses and interest rate details.
- Assess the impact of the 56,167,665 new shares on existing shareholder dilution.
- Monitor subsequent filings for any missed payments or failure to meet the February 28, 2026 relisting deadline.